Iceland - Diabetes Medicine Use
Since 2014, Iceland Diabetes Medicine Use grew 2.8% year on year. With 48.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 25 comparing other countries in Diabetes Medicine Use. Iceland is overtaken by Lithuania, which was ranked number 24 at 54.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Latvia at 48.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Finland topped the ranking with 97.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 1.6% versus 2018. Czech Republic, Canada and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada recorded the best 5 years average growth at +9.6% per year, while Chile witnessed the worst performance at -1.6% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 48.80 |
| 2018 | 48.60 |
| 2017 | 47.90 |
| 2016 | 46.90 |
| 2015 | 45.10 |
How does Iceland rank in Diabetes Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Finland
|
97 | 2019 | +1.6 % | +2.0 % | View data | |
| 2 |
#2
Czech Republic
|
93 | 2019 | +2.8 % | +1.9 % | View data | |
| 24 |
#24
Lithuania
|
54 | 2019 | +1.3 % | +4.4 % | View data | |
| 25 |
#25
Iceland
|
49 | 2019 | +0.4 % | +2.8 % | View data | |
| 26 |
#26
Latvia
|
49 | 2019 | +3.9 % | +2.7 % | View data | |